David Slade

CEO, Slade / Executive Director
David leads Icon's compounding service with a deep understanding of the healthcare industry and a commitment to every customer and patient.
Follow David on LinkedIn

From the moment you meet David you know his integrity runs through every part of the Slade business. His dedication to customers, commitment to patient care and vision has seen the company become a leading national provider of hospital and compounding pharmacy services.

His deep understanding of the healthcare industry not only underpins the 50 year old Slade Pharmacy business, but has been integral to the evolution of Slade Health. Seeing an opportunity to evolve outside of pharmacy, David established Slade Health in 2012. He recently led the acquisition of Fresenius Kabi and McBeath Oncology Compounding, which makes Slade Health one of Australia’s largest chemotherapy compounders.

David is passionate about innovation and using technology to improve the operations of the business. He was the first in Australia to introduce robotic dispensing technology into hospital pharmacy, develop and deploy an online ordering system for chemotherapy and unique barcoding technology to support patient safety in hospitals.

Back to Board

Search

Contact us